Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other neoplasm 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Neoadjuvant Chemoimmunotherapy 1

Interventions

Carboplatin 195 pembrolizumab 158 Pemetrexed 136 Cisplatin 119 durvalumab 73 Paclitaxel 72 osimertinib 68 Nivolumab 66 Docetaxel 63 Specimen Handling 61 atezolizumab 58 Magnetic Resonance Spectroscopy 50 Etoposide 47 Gemcitabine 42 Radiotherapy 39 Radiosurgery 37 130-nm albumin-bound paclitaxel 34 Drug Therapy 30 Cetuximab 28 Bevacizumab 27 Ipilimumab 25 Taxes 23 cemiplimab 22 tislelizumab 21 Platinum 20 Radiation 19 amivantamab 18 Immunoglobulin G 17 1,2-diaminocyclohexaneplatinum II citrate 17 Disulfides 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Robotic Surgical Procedures × Thoracic × 90 days × Clear all

NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Neoadjuvant Chemoimmunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡